Publicly-traded company Pulse Biosciences Inc. (NASDAQ:PLSE) had a closing price of $14.05 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $26.00, this means that the stock is underpriced by 45.96%. In the past 52 weeks the company’s stock price has moved within the range of $9.52 to $19.77.
This particular stock’s 5-day moving average is 14.30, its 20-day moving average is 14.18 and its 100-day moving average is 13.62. Pulse Biosciences Inc. (PLSE) currently has 20.67M shares outstanding, which means that its market capitalization is $290.41M.
The Details: Pulse Biosciences Inc. (PLSE) Financial Health
We can also find the company’s Return on Assets, which is a percentage that shows us how well a company uses its current assets to make a profit. The larger the score, the better. At the moment, Pulse Biosciences Inc. Return on Assets is -70.30%.
What Does Wall Street Say about Company?
When considering a stock buy, many investors seek to know what Wall Street analysts are saying about the company – by looking at the average analyst rating, for example. At the moment, the average analyst rating for PLSE is Buy. Out of 1 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 1 rated it a Buy.
Understanding Profitability at Pulse Biosciences Inc. (PLSE)
A smart way of assessing a company’s profitability is by checking out its latest Earnings per Share (EPS). In the most recent financial results released by Pulse Biosciences Inc., for the quarter ending on 12/2019, the company posted EPS of -0.61. The average estimate of Wall Street analysts had projected -0.61.